Profilaxis postexposición al virus de la inmunodeficiencia humana no ocupacional. Conocimientos y prácticas de profesionales y grupos con conductas de riesgo

Almeda, Jesús; Allepuz, Alejandro; Simon, B; Blasco, Juan Antonio; Esteve, Anna; Barbarà, Jordi Casabona i

doi:10.1016/s0025-7753(03)73937-2

Cited by 7 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data are sparse on nPEP for drug users in general and for IDUs in particular, 35,36 and results of PrEP trials in IDUs are not yet available. 37 Should the data show effectiveness, the next challenge will be to appropriately disseminate information via street outreach strategies.…”

Section: Where Are We Now?mentioning

confidence: 99%

Progress in HIV Reduction and Prevention Among Injection and Noninjection Drug Users

Crawford¹,

Vlahov²

2010

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

Substantial progress has been made in reducing HIV among injection drug users (IDUs) in the United States, despite political and social resistance that reduced resources and restricted access to services. The record for HIV prevention among noninjecting drug users is less developed, although they are more numerous than IDUs. Newer treatments for opiate and alcohol abuse can now be integrated into primary HIV care; treatment for stimulant abuse is less developed. All drug users present challenges for newer HIV prevention strategies (eg, “test and treat,” nonoccupational postexposure prophylaxis and pre-exposure prophylaxis, contingency management, and conditional cash transfer). A comprehensive HIV prevention program that includes multicomponent, multilevel approaches (ie, individual, network, structural) has been effective in HIV prevention among IDUs. Expanding these approaches to noninjecting drug users, especially those at highest risk (eg, minority men who have sex with men) and incorporating these newer approaches is a public health priority.

show abstract

Section: Where Are We Now?mentioning

confidence: 99%

Progress in HIV Reduction and Prevention Among Injection and Noninjection Drug Users

Crawford¹,

Vlahov²

2010

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

show abstract

P0756 Assessment of Knowledge and Attitudes of Newly-Qualified Doctors Towards Aids Infection

Kyriazis¹,

Mellos²,

Theodoropoulou³

et al. 2009

European Journal of Internal Medicine

View full text Add to dashboard Cite

End Users’ Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development

Beanland

Irvine

Green³

2015

Clinical Infectious Diseases

View full text Add to dashboard Cite

The 2014 World Health Organization guidelines for human immunodeficiency virus postexposure prophylaxis (PEP) are the first to combine recommendations for all populations and exposures. To inform the development of these guidelines, we gathered views of end users on key aspects of PEP provision. A mixed-methods approach was used to gather views from the populations for whom the guideline will be of relevance. Data gathered from an online survey, focus group discussions, and previously collected data from in-depth interviews with key populations were used to inform the development of recommendations, in particular where there is a paucity of evidence to assess the benefits and harms of an intervention. This was a successful method to gather end users' views and preferences; however, limitations exist in the generalizability and reliability of the evidence. Future guideline development processes should consider methods to include the views of end users to guide the decision-making process.

show abstract

Profilaxis postexposición al virus de la inmunodeficiencia humana no ocupacional. Conocimientos y prácticas de profesionales y grupos con conductas de riesgo

Cited by 7 publications

References 12 publications

Progress in HIV Reduction and Prevention Among Injection and Noninjection Drug Users

Progress in HIV Reduction and Prevention Among Injection and Noninjection Drug Users

P0756 Assessment of Knowledge and Attitudes of Newly-Qualified Doctors Towards Aids Infection

End Users’ Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development

Contact Info

Product

Resources

About